Cell Signaling Technology

Phospho-SAPK/JNK (Thr183/Tyr185) (G9) Mouse Monoclonal Antibody (PE Conjugate)

#5755 · $493

100
Citing papers
8.4k
Combined citations
Supplier page Find this product

Research areas

Adipose Tissue and Metabolism20Lipid metabolism and biosynthesis10Cancer-related molecular mechanisms research9RNA Research and Splicing8Metabolism, Diabetes, and Cancer7Cancer-related Molecular Pathways6Cytokine Signaling Pathways and Interactions5Adipokines, Inflammation, and Metabolic Diseases5

Papers citing this product

1
Acute exercise increases triglyceride synthesis in skeletal muscle and prevents fatty acid–induced insulin resistance
Journal of Clinical Investigation·2007·403 cit.·DOI
2
MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition
The Journal of Experimental Medicine·2012·395 cit.·DOI
3
Skeletal Muscle Triglycerides, Diacylglycerols, and Ceramides in Insulin Resistance
Diabetes·2011·385 cit.·DOI
4
Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance
Journal of Clinical Investigation·2007·344 cit.·DOI
5
Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers
British Journal of Cancer·2013·288 cit.·DOI
6
Moderate-Intensity Exercise and High-Intensity Interval Training Affect Insulin Sensitivity Similarly in Obese Adults
The Journal of Clinical Endocrinology & Metabolism·2020·195 cit.·DOI
7
Inactivation of IL11 Signaling Causes Craniosynostosis, Delayed Tooth Eruption, and Supernumerary Teeth
The American Journal of Human Genetics·2011·193 cit.·DOI
8
MEIOB exhibits single-stranded DNA-binding and exonuclease activities and is essential for meiotic recombination
Nature Communications·2013·176 cit.·DOI
9
Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02
Neuro-Oncology·2014·166 cit.·DOI
10
Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours
British Journal of Cancer·2019·165 cit.·DOI

Similar products

ProductVendorPricePapers
Phospho-SAPK/JNK (Thr183/Tyr185) Matched Antibody PairCell Signaling Technology$1,726200
Phospho-SAPK/JNK (Thr183/Tyr185) (81E11) Rabbit Monoclonal Antibody (Sepharose Bead Conjugate)RabbitCell Signaling Technology$493100
PhosphoPlus® SAPK/JNK (Thr183/Tyr185) Antibody DuetCell Signaling Technology$673100
Phospho-SAPK/JNK (Thr183/Tyr185) (G9) Mouse Monoclonal Antibody (BSA and Azide Free)MouseCell Signaling Technology$898100
Phospho-SAPK/JNK (Thr183/Tyr185) (G9) Mouse Monoclonal AntibodyMouseCell Signaling Technology$193100
Phospho-SAPK/JNK (Thr183/Tyr185) (81E11) Rabbit Monoclonal AntibodyRabbitCell Signaling Technology$169100
Phospho-SAPK/JNK (Thr183/Tyr185) (98F2) Rabbit Monoclonal AntibodyRabbitCell Signaling Technology$178100
Phospho-SAPK/JNK (Thr183/Tyr185) AntibodyRabbitCell Signaling Technology$366100
Phospho-SAPK/JNK (Thr183/Tyr185) (G9) Mouse Monoclonal Antibody (Alexa Fluor® 647 Conjugate)MouseCell Signaling Technology$49388
Phospho-SAPK/JNK (Thr183/Tyr185) (81E11) Rabbit Monoclonal Antibody (BSA and Azide Free)RabbitCell Signaling Technology$8984
Phospho-SAPK/JNK (Thr183/Tyr185) AntibodyrabbitCell Signaling Technology——